Eptinezumab
Vyepti (eptinezumab) is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against calcitonin; calcitonin gene-related peptide 1 and calcitonin gene-related peptide 2.
Trade Name |
Vyepti |
---|---|
Common Name |
eptinezumab |
ChEMBL ID |
CHEMBL3833320 |
Indication |
|
Drug Class |
Monoclonal antibodies: humanized, neural indications |
Image (chem structure or protein)

$4,995
Want to know more?
Schedule a demo or contact us for additional purchasing options.
Every Drug Dataset Includes...
Full dataset compatible with-

SQL for web applications

R for statistical modeling

Spotfire & Tableau for visualization

CSV export file format

JSON export file format

XLSX export file format
Continually updated information available as a yearly subscription for individual drug-of-interest.